22 matches for your search in the start-up spotlight
rssAbselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge. We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend ...
Together, we stand at the brink of a journey, charging forth to redefine energy. Systems-level innovation, born from a decade of shared dedication between world-class technicians, scientists, and experts. We believe in a collaborative approach to innovation and a systems-level approach to ...
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base ...
Technology to support sustainable agriculture one microbe at a time. Chemical fertilizers and pesticides have long been the go to solution for farmers looking to enhance their yields. We believe that nature has a viable alternative to replace chemicals, it just needs some help. We have developed ...
Mogrify has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and ...
Broken String Biosciences is a genomics company with the goal of developing safer cell and gene therapies by assessing the stability of the genome. The Company is building a technology platform pipeline that will drive the development of cell and gene therapies that are safer by design. Its core ...
Camena Bioscience is a synthetic biology company with novel DNA synthesis technology. Built on over 7 years of innovation and with deep insight to the challenges faced in the pharmaceutical and biotechnology industries, their pioneering platform gSynth™ is rewriting the possibilities of DNA ...
Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK. Our mission is to unlock the full potential of the human genome’s 3D ...
Evonetix is a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists’ ability to use biology on a scale not currently ...
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. By using microchip industry materials and techniques we are revolutionizing in vitro research on cell models to help create better medicines, ...